OverviewChartNewsTraderScreen

DZ Bank Discount Zert GILD 27.09..../  DE000DJ5H7M7  /

Frankfurt Zert./DZB
2024-06-10  9:34:18 PM Chg.+0.470 Bid9:59:56 PM Ask- Underlying Strike price Expiration date Option type
59.280EUR +0.80% 59.450
Bid Size: 1,000		 -
Ask Size: -		 Gilead Sciences Inc - USD 2024-09-27 Call
GlobeNewswire 06-10 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...
GlobeNewswire 05-22 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congres...
GlobeNewswire 05-14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 05-09 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 05-09 HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 05-08 Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire 04-29 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...
GlobeNewswire 04-19 ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies...
GlobeNewswire 04-10 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire 04-03 Opthea Appoints Sujal Shah to the Board of Directors
GlobeNewswire 04-02 Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
GlobeNewswire 04-02 Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
GlobeNewswire 04-01 Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Fin...
GlobeNewswire 03-28 Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlight...
GlobeNewswire 03-28 Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
GlobeNewswire 03-28 Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
GlobeNewswire 03-22 HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
GlobeNewswire 03-18 CIO Celebrates Innovations in Business Technology with 2024 CIO 100 & Hall of Fame Awards
GlobeNewswire 03-11 Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...
GlobeNewswire 02-29 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay The...
GlobeNewswire 02-29 Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences; Establishes J...
GlobeNewswire 02-28 CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corpo...
GlobeNewswire 02-27 MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
GlobeNewswire 02-24 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CBAY, IONM, WISH, FREE